New Zealand markets close in 42 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.20-0.14 (-2.62%)
At close: 4:00PM EDT
5.22 +0.02 (+0.38%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 51.44B
Enterprise value 31.09B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)81.40
Price/book (mrq)4.16
Enterprise value/revenue 382.76
Enterprise value/EBITDA 7-23.05

Trading information

Stock price history

Beta (5Y monthly) 1.98
52-week change 3862.96%
S&P500 52-week change 331.29%
52-week high 315.69
52-week low 30.47
50-day moving average 35.37
200-day moving average 36.08

Share statistics

Avg vol (3-month) 37.55M
Avg vol (10-day) 35.9M
Shares outstanding 5279.14M
Implied shares outstanding 6N/A
Float 8276.09M
% held by insiders 10.34%
% held by institutions 127.01%
Shares short (29 Sep 2021) 440.33M
Short ratio (29 Sep 2021) 45.19
Short % of float (29 Sep 2021) 414.45%
Short % of shares outstanding (29 Sep 2021) 414.45%
Shares short (prior month 30 Aug 2021) 445.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 0.00%
Operating margin (ttm)-359.56%

Management effectiveness

Return on assets (ttm)-15.46%
Return on equity (ttm)-29.15%

Income statement

Revenue (ttm)13.21M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)226.20%
Gross profit (ttm)2.77M
EBITDA -45.64M
Net income avi to common (ttm)-51.26M
Diluted EPS (ttm)-0.25
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)332.55M
Total cash per share (mrq)1.19
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)31.87
Book value per share (mrq)1.24

Cash flow statement

Operating cash flow (ttm)-49.39M
Levered free cash flow (ttm)-22.89M